ビサコジル市場：投与タイプ、用途、流通チャネル別-2025～2030年の世界予測

ビサコジル市場は、2023年に12億8,000万米ドルと評価され、2024年には13億5,000万米ドルに達すると予測され、CAGR 6.49%で成長し、2030年には19億9,000万米ドルに達すると予測されています。

ビサコジルは刺激性下剤で、主に便通を刺激して便秘を治療するために使用されます。市場調査では、その範囲は胃腸治療の医薬品セグメントを包含します。ビサコジルの必要性は、高齢者や腸の不規則な動きを引き起こす薬剤治療を受けている患者など、さまざまな集団における便秘や腸の管理という一般的な問題から生じています。その用途は経口剤と坐剤の両方に及ぶため、患者のニーズや嗜好の違いに柔軟に対応できます。最終用途の範囲は病院、クリニック、個人的な在宅ケアに及び、市場の大きな需要に貢献しています。ビサコジル市場に影響を与える主要成長要因としては、生活習慣に関連した消化器疾患の発生率の増加、胃腸の健康に対する意識の高まり、定期的な下剤を必要とすることが多い世界人口の高齢化などが挙げられます。最新のビジネス機会としては、医療へのアクセスが改善しつつある新興国市場への進出、より迅速な緩和と副作用軽減のための革新的製剤の開発が挙げられます。こうした機会を活用するための提言としては、医療プロバイダーとの戦略的パートナーシップや、定期的な腸の健康に関する消費者の意識を高めるための教育キャンペーンが挙げられます。市場の成長は、腹部のけいれんや下痢などの潜在的な副作用、自然療法を含む代替治療の選択肢、医薬品の承認と販売に関する規制上の制約などの限界に直面しています。競合情勢はさらに、ジェネリック医薬品による価格戦略の制約という課題もあります。イノベーションは、副作用を最小限に抑えた、より穏やかで標的を絞った製剤の調査や、予防医療における使用事例の拡大を通じて促進することができます。ビサコジルの使用と連動した消化器の健康状態をモニタリングするアプリなど、デジタルヘルスの統合も患者のアドヒアランスと転帰を高める可能性があります。市場は緩やかな成長と競合を特徴とし、基本的な健康ニーズと下剤デリバリーソリューションの革新的な進歩がその原動力となっています。

市場力学：急速に進化するビサコジル市場の主要市場洞察を公開

ビサコジル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 便秘と神経因性腸機能障害の有病率の上昇
  • 市販薬の採用増加
• 市場抑制要因
  • ビサコジルの製造に使用される原料の価格変動
• 市場機会
  • 革新的な製剤とドラッグデリバリー方法の研究開発の継続
  • 製造方法の技術的進歩
• 市場課題
  • ビサコジルの代替品の入手可能性

ポーターのファイブフォース：ビサコジル市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、ビサコジル市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ビサコジル市場における外部からの影響の把握

外部マクロ環境要因は、ビサコジル市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：ビサコジル市場における競合情勢の把握

ビサコジル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：ビサコジル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ビサコジル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：ビサコジル市場における成功への道筋を描く

ビサコジル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 便秘と神経性腸機能障害の有病率の上昇
    • 市販薬の採用増加ビサコジル
  • 抑制要因
    • ビサコジルの製造に使用される原料の変動価格
  • 機会
    • 革新的な薬剤配合と投与方法の継続的な研究開発
    • 製造方法における技術的進歩
  • 課題
    • ビサコジルの代替品の可用性
• 市場セグメンテーション分析
  • 投与タイプ：市販薬（OTC）経口薬の大幅な採用ビサコジル
  • 用途：便秘と神経性腸機能障害の管理におけるビサコジルの利用率の向上
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 ビサコジル市場：管理タイプ別

• イントロダクション
• 経口薬
• 坐薬

第7章 ビサコジル市場：用途別

• イントロダクション
• 便秘
• 神経性腸機能障害

第8章 ビサコジル市場：流通チャネル別

• イントロダクション
• 病院薬局
• オンライン薬局
• 小売薬局

第9章 南北アメリカのビサコジル市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のビサコジル市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのビサコジル市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • AbbVie、米国FDAにリンゼス（リナクロチド）の6～17歳の小児と青少年の機能性便秘に対する新たな適応症の追加申請を提出
• 戦略分析と提言

企業一覧

• Cambrex Corporation
• Carbogen AMCIS
• Centurion Remedies Private Limited
• Cipla Limited
• Dr. Reddy's Laboratories
• Enomark
• Erregierre Spa
• GlaxoSmithKline plc
• Joshi Agrochem Pharma
• Kreative Organics Private Limited
• Lexicare Pharma Pvt. Ltd.
• LMG Pharma
• Mahendra Chemicals
• Manus Aktteva Biopharma LLP
• Merck KGaA
• Sanofi S.A.
• Tiefenbacher API+Ingredients GmbH & Co. KG
• Zuche Pharmaceuticals Pvt. Ltd.

LIST OF FIGURES

• FIGURE 1. BISACODYL MARKET RESEARCH PROCESS
• FIGURE 2. BISACODYL MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BISACODYL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BISACODYL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BISACODYL MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BISACODYL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BISACODYL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BISACODYL MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BISACODYL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BISACODYL MARKET DYNAMICS
• TABLE 7. GLOBAL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BISACODYL MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BISACODYL MARKET SIZE, BY SUPPOSITORY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BISACODYL MARKET SIZE, BY CONSTIPATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BISACODYL MARKET SIZE, BY NEUROGENIC BOWL DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BISACODYL MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BISACODYL MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BISACODYL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 27. CANADA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 28. CANADA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. CANADA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 30. MEXICO BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 33. UNITED STATES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES BISACODYL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 37. ASIA-PACIFIC BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 41. AUSTRALIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 44. CHINA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CHINA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. CHINA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 47. INDIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 48. INDIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. INDIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 50. INDONESIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 53. JAPAN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 56. MALAYSIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 59. PHILIPPINES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 62. SINGAPORE BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 65. SOUTH KOREA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 68. TAIWAN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 71. THAILAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 74. VIETNAM BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 77. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA BISACODYL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 81. DENMARK BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 84. EGYPT BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 87. FINLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 90. FRANCE BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 93. GERMANY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 96. ISRAEL BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 99. ITALY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ITALY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ITALY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 102. NETHERLANDS BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 105. NIGERIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 108. NORWAY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 111. POLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 112. POLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. POLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 114. QATAR BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 115. QATAR BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. QATAR BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 117. RUSSIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 120. SAUDI ARABIA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH AFRICA BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 126. SPAIN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 129. SWEDEN BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 132. SWITZERLAND BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 135. TURKEY BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 138. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 141. UNITED KINGDOM BISACODYL MARKET SIZE, BY ADMINISTRATION TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM BISACODYL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM BISACODYL MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
• TABLE 144. BISACODYL MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 145. BISACODYL MARKET, FPNV POSITIONING MATRIX, 2023

The Bisacodyl Market was valued at USD 1.28 billion in 2023, expected to reach USD 1.35 billion in 2024, and is projected to grow at a CAGR of 6.49%, to USD 1.99 billion by 2030.

Bisacodyl, a stimulant laxative, is primarily used to treat constipation by stimulating bowel movements. In market research, its scope encompasses the pharmaceutical segment of gastrointestinal treatments. The necessity for bisacodyl arises from the prevalent issues of constipation and bowel management in various populations, including the elderly and patients under medication regimens that cause bowel irregularity. Its application spans both oral and suppository forms, making it flexible for different patient needs and preferences. End-use scope extends across hospitals, clinics, and personal at-home care, contributing to its substantial market demand. Key growth factors influencing the bisacodyl market include the increasing incidence of lifestyle-related digestive disorders, growing awareness about gastrointestinal health, and the aging global population, which often requires regular laxative solutions. The latest opportunities highlight the expansion into emerging markets where healthcare access is improving, as well as developing innovative formulations for faster relief and reduced side effects. Recommendations to leverage these opportunities involve strategic partnerships with healthcare providers and educational campaigns to increase consumer awareness about regular bowel health. Nevertheless, market growth faces limitations such as potential side effects like abdominal cramping and diarrhea, alternative treatment options including natural remedies, and regulatory constraints on drug approval and marketing. The competitive landscape is further challenged by generic alternatives, which may restrict pricing strategies. Innovation can thrive through research into gentler, targeted formulations that minimize side effects, as well as expanding use-cases in preventive care. Digital health integrations, such as apps for monitoring digestive health linked with bisacodyl usage, could also enhance patient adherence and outcomes. The market is characterized by moderate growth and competition, driven by fundamental health needs and innovative advancements in laxative delivery solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bisacodyl Market

The Bisacodyl Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of constipation and neurogenic bowel dysfunction
  • Increasing adoption of over-the-counter bisacodyl drug
• Market Restraints
  • Volatile prices of raw materials used in manufacturing of bisacodyl
• Market Opportunities
  • Ongoing research & developments for innovative drug formulation and delivery methods
  • Technological advancements in manufacturing methods
• Market Challenges
  • Availability of alternative to bisacodyl

Porter's Five Forces: A Strategic Tool for Navigating the Bisacodyl Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bisacodyl Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bisacodyl Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bisacodyl Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bisacodyl Market

A detailed market share analysis in the Bisacodyl Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bisacodyl Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bisacodyl Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bisacodyl Market

A strategic analysis of the Bisacodyl Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bisacodyl Market, highlighting leading vendors and their innovative profiles. These include Cambrex Corporation, Carbogen AMCIS, Centurion Remedies Private Limited, Cipla Limited, Dr. Reddy's Laboratories, Enomark, Erregierre Spa, GlaxoSmithKline plc, Joshi Agrochem Pharma, Kreative Organics Private Limited, Lexicare Pharma Pvt. Ltd., LMG Pharma, Mahendra Chemicals, Manus Aktteva Biopharma LLP, Merck KGaA, Sanofi S.A., Tiefenbacher API + Ingredients GmbH & Co. KG, and Zuche Pharmaceuticals Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Bisacodyl Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Administration Type, market is studied across Oral Medications and Suppository Medications.
• Based on Application, market is studied across Constipation and Neurogenic Bowl Dysfunction.
• Based on Distribution Channels, market is studied across Hospital Pharmacy, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of constipation and neurogenic bowel dysfunction
    • 5.1.1.2. Increasing adoption of over-the-counter bisacodyl drug
  • 5.1.2. Restraints
    • 5.1.2.1. Volatile prices of raw materials used in manufacturing of bisacodyl
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research & developments for innovative drug formulation and delivery methods
    • 5.1.3.2. Technological advancements in manufacturing methods
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative to bisacodyl
• 5.2. Market Segmentation Analysis
  • 5.2.1. Administration Type: Significant adoption of over-the-counter (OTC) oral bisacodyl
  • 5.2.2. Application: Increasing utilization of bisacodyl in managing constipation and neurogenic bowel dysfunction
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bisacodyl Market, by Administration Type

• 6.1. Introduction
• 6.2. Oral Medications
• 6.3. Suppository Medications

7. Bisacodyl Market, by Application

• 7.1. Introduction
• 7.2. Constipation
• 7.3. Neurogenic Bowl Dysfunction

8. Bisacodyl Market, by Distribution Channels

• 8.1. Introduction
• 8.2. Hospital Pharmacy
• 8.3. Online Pharmacies
• 8.4. Retail Pharmacies

9. Americas Bisacodyl Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Bisacodyl Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Bisacodyl Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. AbbVie Submits Supplemental New Drug Application to U.S. FDA to Support New Indication of LINZESS (linaclotide) for Functional Constipation in Children and Adolescents 6 to 17 Years of Age
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Cambrex Corporation
• 2. Carbogen AMCIS
• 3. Centurion Remedies Private Limited
• 4. Cipla Limited
• 5. Dr. Reddy's Laboratories
• 6. Enomark
• 7. Erregierre Spa
• 8. GlaxoSmithKline plc
• 9. Joshi Agrochem Pharma
• 10. Kreative Organics Private Limited
• 11. Lexicare Pharma Pvt. Ltd.
• 12. LMG Pharma
• 13. Mahendra Chemicals
• 14. Manus Aktteva Biopharma LLP
• 15. Merck KGaA
• 16. Sanofi S.A.
• 17. Tiefenbacher API + Ingredients GmbH & Co. KG
• 18. Zuche Pharmaceuticals Pvt. Ltd.